Evidence suggests that among the myeloid colony-stimulating factors (CSFs), macrophage-CSF (M-CSF) is important in normal development of osteoclasts. To understand the role of M-CSF and other myeloid CSFs on clonal growth of osteoclast progenitors, isolated monkey bone marrow cells expressing the CD34 antigen were grown in soft agar or methylcellulose cultures in the presence of recombinant human M-CSF, granulocyte-macrophage CSF (GM-CSF), interleukin-3 (IL-3), calcitriol and various combinations of these factors. Day-10 to day-20 colonies were stained for tartrate-resistant acid phosphatase (TRAP) in order to identify putative osteoclast progenitors. Colonies were scored as follows: if greater than 80% of the cells in a colony contained TRAP it was scored as TRAP-positive; between 20% and 80%, TRAP-mix; and less than 20%, TRAP-negative. Further identification of osteoclast progenitors was made by simultaneous autoradiographic detection of calcitonin receptors on TRAP-stained colonies grown in methylcellulose. Among the 3 CSFs tested alone, GM-CSF stimulated the greatest number of TRAP-positive colonies; however, M-CSF and IL-3 in combination stimulated an even greater number of TRAP-positive colonies at all time points. Such additive effect was not observed between GM-CSF and IL-3. When calcitriol was added, the following increases in day-20 TRAP-positive colonies occurred: with M-CSF, 189%; with IL-3, 109%; with the combination of M-CSF and IL-3, 52%; and with GM-CSF there was no change. In the presence of calcitriol, 75% of IL-3 plus M-CSF-induced TRAP-containing colonies demonstrated calcitonin receptors over their TRAP-positive cells, whereas with M-CSF, GM-CSF or IL-3 each alone, 0 to 25% of TRAP-containing colonies had calcitonin receptor over TRAP-positive cells. These results suggest that IL-3, M-CSF and calcitriol stimulate a subpopulation of hemopoietic progenitors, likely osteoclast progenitors, that can give rise to TRAP-positive cells simultaneously expressing calcitonin receptors.

Download full-text PDF

Source

Publication Analysis

Top Keywords

osteoclast progenitors
16
m-csf il-3
12
calcitonin receptors
12
trap-positive colonies
12
trap-positive cells
12
m-csf
9
il-3
9
recombinant human
8
human m-csf
8
bone marrow
8

Similar Publications

Epiregulin ameliorates ovariectomy-induced bone loss through orchestrating the differentiation of osteoblasts and osteoclasts.

J Bone Miner Res

January 2025

NHC Key Lab of Hormones and Development, Tianjin Key Lab of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China.

Epiregulin plays a role in a range of biological activities including malignancies. This study aims to investigate the potential contribution of epiregulin to bone cell differentiation and bone homeostasis. The data showed that epiregulin expression was upregulated during osteogenesis but downregulated during adipogenesis.

View Article and Find Full Text PDF

Purpose Of Review: The purpose of this review is to summarize the current understanding of cell-autonomous innate immune pathways that contribute to bone homeostasis and disease.

Recent Findings: Germ-line encoded pattern recognition receptors (PRRs) are the first line of defense against danger and infections. In the bone microenvironment, PRRs and downstream signaling pathways, that mount immune defense, interface intimately with the core cellular processes in bone cells to alter bone formation and resorption.

View Article and Find Full Text PDF

Sickle cell disease (SCD) is a severe hematological disorder characterized by erythrocyte sickling that causes significant morbidity and mortality. Skeletal complications of SCD include a high incidence of bone loss, especially in vertebrae, leading to fragility fractures that contribute to disease burden. Whether hydroxyurea (HU), a front-line therapy for SCD ameliorates bone disease has not been established.

View Article and Find Full Text PDF

Negative feedback between PTH1R and IGF1 through the Hedgehog pathway in mediating craniofacial bone remodeling.

JCI Insight

December 2024

State Key Laboratory of Oral Diseases, National Center for Stomatology, Nat, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Regeneration of orofacial bone defects caused by inflammatory-related diseases or trauma remains an unmet challenge. Parathyroid hormone 1 receptor (PTH1R) signaling is a key mediator of bone remodeling whereas the regulatory mechanisms of PTH1R signaling in oral bone under homeostatic or inflammatory conditions have not been demonstrated by direct genetic evidence. Here we observed that deletion of PTH1R in Gli1+-progenitors led to increased osteogenesis and osteoclastogenesis.

View Article and Find Full Text PDF

Molecular Mechanisms of Curdlan-Induced Suppression of NFATc1 Expression in Osteoclasts.

J Cell Biochem

January 2025

Division of Infections and Molecular Biology, Department of Health Promotion, Kyushu Dental University, Kitakyushu, Fukuoka, Japan.

Article Synopsis
  • - Curdlan, a β-glucan, inhibits the formation of osteoclasts—cells that break down bone—by binding to dectin-1, leading to reduced expression of NFATc1, a key factor for osteoclast differentiation.
  • - The study investigates how curdlan disrupts RANKL-induced NFATc1 expression and finds that it also affects the NF-κB signaling pathway, which is crucial for NFATc1 activation.
  • - Additionally, the research indicates a dectin-1-independent mechanism involving complement receptor 3 (CR3), suggesting that curdlan's effects on osteoclast differentiation are multifaceted and involve multiple pathways.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!